Lifestyle
What Happens to Fasting Glucose During Pregnancy?
Fasting glucose changes are a normal part of pregnancy physiology — but not all changes are benign. Gestational diabetes affects roughly 6–9% of pregnancies in the U.S., and catching the early signal in a fasting glucose number can change outcomes for both mother and baby. Here's what the research actually shows.
What Happens to Fasting Glucose During Pregnancy?
Fasting glucose naturally drops slightly in early pregnancy due to increased insulin sensitivity and glucose uptake by the placenta, then rises in the second and third trimesters as placental hormones drive insulin resistance. For most healthy pregnancies, the body compensates fully. The exception is gestational diabetes mellitus (GDM), where beta-cell function can't keep pace — affecting roughly 6–9% of U.S. pregnancies and requiring active management.
---
The Normal Physiology: Why Glucose Shifts Throughout Pregnancy
Pregnancy is not a static metabolic state. From implantation through delivery, glucose metabolism undergoes predictable, hormonally driven changes that serve a clear purpose: ensuring the fetus has a continuous glucose supply.
First trimester: Estrogen and progesterone rise sharply, increasing peripheral insulin sensitivity. Maternal fasting glucose typically falls by 5–10 mg/dL compared to pre-pregnancy baseline. Studies using continuous glucose monitoring in healthy pregnant women confirm that mean fasting glucose values in the first trimester often sit between 70–80 mg/dL — lower than non-pregnant norms (Hernandez et al., Diabetes Care 2011; PMID: 21593296).
Second trimester: The placenta begins secreting human placental lactogen (hPL), progesterone, cortisol, and prolactin in increasing amounts. These counter-regulatory hormones progressively blunt insulin signaling at the receptor level — a deliberate physiological adaptation to redirect glucose toward the fetus. Maternal insulin secretion must increase 2–2.5-fold just to maintain euglycemia (Catalano et al., American Journal of Obstetrics and Gynecology 1993; PMID: 8498421).
Third trimester: Insulin resistance peaks. Fasting glucose in healthy pregnancies may edge upward compared to first-trimester lows, but still remains well within normal range (below 92 mg/dL by ADA criteria). The placenta is now a major glucose consumer, pulling roughly 30–40% of maternal glucose output at any given moment.
This metabolic flexibility is elegant when it works. When beta-cell reserve is insufficient to meet the rising demand, fasting glucose climbs above safe thresholds — and gestational diabetes is the result.
---
What Counts as Abnormal Fasting Glucose During Pregnancy?
The diagnostic thresholds for gestational diabetes differ from standard adult diabetes criteria, and they've been revised downward over the past decade based on the HAPO study — a landmark multicenter trial of over 23,000 mother-infant pairs that showed continuous, graded relationships between maternal glucose and adverse outcomes at levels previously considered "normal" (HAPO Study Cooperative Research Group, New England Journal of Medicine 2008; PMID: 18463375).
| Timepoint | Normal Fasting Glucose | GDM Threshold (IADPSG/ADA) |
|---|---|---|
| First trimester | 70–85 mg/dL | ≥92 mg/dL |
| Second trimester | 75–90 mg/dL | ≥92 mg/dL |
| Third trimester | 80–95 mg/dL | ≥92 mg/dL |
| 75g OGTT — 1-hour | — | ≥180 mg/dL |
| 75g OGTT — 2-hour | — | ≥153 mg/dL |
The International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria, adopted by the ADA in 2011, use a one-step 75g oral glucose tolerance test (OGTT) at 24–28 weeks. A fasting value of 92 mg/dL or above on that test alone is sufficient for a GDM diagnosis — you don't need to fail the post-load reading. This is significantly lower than the 95 mg/dL threshold used in older two-step protocols, which is why GDM prevalence numbers shifted after guideline adoption.
For context on what fasting glucose tells you more broadly, see what fasting glucose tells you about your hormones.
---
Risk Factors That Make Glucose Dysregulation More Likely
Not every pregnant person faces the same risk of GDM. Several factors consistently elevate risk across population studies:
- Pre-pregnancy insulin resistance: Women with fasting glucose at the high end of normal (85–99 mg/dL) before conception have significantly greater GDM risk. If you've ever been curious about what causes fasting insulin to be out of range, that upstream insulin signal matters even before pregnancy begins.
- BMI above 30: Adipose tissue amplifies baseline insulin resistance, leaving less buffer for the second-trimester surge in counter-regulatory hormones.
- Family history of type 2 diabetes: Beta-cell capacity has a significant heritable component.
- History of GDM in a prior pregnancy: Risk of recurrence exceeds 40% in most cohorts.
- Polycystic ovary syndrome (PCOS): PCOS is itself a state of hyperinsulinemia; the overlapping insulin resistance markedly increases GDM susceptibility.
- Age above 35: Declining beta-cell reserve with age reduces compensatory capacity.
- Ethnicity: South Asian, Black, Hispanic, and Indigenous populations show higher GDM rates independent of BMI, likely reflecting both genetic and socioenvironmental factors.
---
What Gestational Diabetes Actually Does to Fasting Glucose
In GDM, the fasting glucose signal reflects overnight hepatic glucose output that is no longer adequately suppressed by insulin. Normally, insulin quiets the liver during a fasted state; in insulin-resistant GDM, the liver continues releasing glucose into circulation unchecked. This is the same mechanism behind elevated fasting glucose in type 2 diabetes — pregnancy just accelerates the timeline dramatically in susceptible individuals.
Postprandial glucose also spikes higher and stays elevated longer, but the fasting number is often the first lab value to cross a threshold because it reflects baseline metabolic tone rather than a meal-driven response.
Untreated GDM is associated with macrosomia (large-for-gestational-age infants), neonatal hypoglycemia, preeclampsia, and a substantially elevated risk of the mother developing type 2 diabetes within 5–10 years postpartum — up to 50% lifetime risk in some cohorts (Kim et al., Diabetes Care 2002; PMID: 11815495).
---
Why Fasting Glucose Can Be Normal and Still Miss the Problem
One of the more counterintuitive findings from continuous glucose monitoring research is that some pregnant women have entirely normal fasting glucose values yet show significant postprandial spikes — glucose exceeding 140 mg/dL for 30–60 minutes after meals — that never appear on a standard fasting lab draw. The HAPO data suggest even these subclinical excursions are associated with increased birth weight and cord-blood insulin levels.
Conversely, some women with modestly elevated fasting glucose (92–99 mg/dL) will have perfectly controlled postprandial responses and minimal fetal risk. This is why the fasting number alone, while important, is only one part of the picture. If your results feel confusing — why fasting glucose is still high despite doing everything right is a useful frame for understanding why the number isn't always telling the full story.
For women specifically wondering whether they should get fasting glucose tested before or during pregnancy, whether women should get fasting glucose tested walks through who benefits most from early screening.
---
Monitoring Protocols: What Testing Actually Looks Like
For women diagnosed with GDM, monitoring frequency depends on treatment pathway:
Diet-managed GDM:
- Fasting glucose on waking (target: <95 mg/dL, many clinicians prefer <90 mg/dL)
- One-hour postprandial after each main meal (target: <140 mg/dL)
- Weekly review with OB or maternal-fetal medicine
Insulin-managed GDM:
- All of the above
- Pre-meal glucose readings to guide dosing
- Possible overnight checks if nocturnal hypoglycemia is a concern
Postpartum, a 75g OGTT at 6–12 weeks is standard to confirm glucose has returned to normal. Many women skip this step — a clinical error, given the long-term T2D risk mentioned above.
---
What This Means for Your Formula
Pregnancy is one of the highest-metabolic-demand phases of a woman's life, and the nutrient requirements that support glucose regulation don't disappear because someone is pregnant — if anything, they intensify. While GDM management is a clinical conversation with an OB or endocrinologist, personalized supplementation built around validated biomarkers can complement that care.
Ones analyzes blood work — including fasting glucose and fasting insulin — alongside health history and wearable data to identify which physiological systems need support. A few ingredients in the Ones catalog are particularly relevant to glucose metabolism and insulin sensitivity:
- Magnesium Glycinate (as part of Ones' Magnesium Complex): Magnesium is a cofactor for over 300 enzymatic reactions, including insulin receptor signaling. Low magnesium status is independently associated with insulin resistance and a higher GDM incidence. A meta-analysis of 13 randomized trials found magnesium supplementation significantly improved fasting glucose and insulin sensitivity in individuals with metabolic risk (Simental-Mendía et al., Magnesium Research 2016; PMID: 27530039).
- Omega-3 (EPA/DHA): Omega-3 fatty acids modulate inflammatory signaling implicated in insulin resistance. Ones includes EPA/DHA dosed to clinically relevant levels, and emerging evidence suggests omega-3 supplementation during pregnancy may modestly reduce inflammatory load — though this is an adjunct, not a GDM treatment.
- Ones' Adrenal Support blend: Chronic stress and HPA axis dysregulation elevate cortisol, which directly raises fasting glucose by stimulating hepatic glucose output. For women dealing with HPA axis suppression or adrenal dysregulation, addressing cortisol patterns is a meaningful part of the glucose picture.
None of these replace insulin therapy or dietary management when GDM is diagnosed. But for women with borderline fasting glucose or elevated GDM risk factors, understanding which nutrient gaps exist — through actual lab data, not guesswork — is precisely where a platform like Ones adds value.
---
Key Takeaways
- Fasting glucose naturally falls in the first trimester due to increased insulin sensitivity, then rises in the second and third trimesters as placental hormones drive insulin resistance.
- GDM is diagnosed when fasting glucose hits 92 mg/dL or above on a 75g OGTT at 24–28 weeks, per current IADPSG/ADA criteria — a threshold lower than most people expect.
- The HAPO trial established that glucose-related risk is continuous, not binary — even levels previously labeled "normal" are associated with graded increases in fetal and maternal outcomes.
- A normal fasting glucose does not rule out postprandial dysregulation — some women spike significantly after meals while their fasting number looks fine.
- Untreated GDM carries a lifetime T2D risk of up to 50% for the mother, making postpartum follow-up essential, not optional.
- Nutrient gaps — particularly magnesium and omega-3s — can influence insulin signaling, and a personalized approach based on actual lab data is more useful than generic prenatal supplementation.
---
Always consult your obstetrician, midwife, or endocrinologist for diagnosis and treatment decisions related to gestational diabetes or any glucose abnormality during pregnancy.